SAN FRANCISCO, CA / ACCESS Newswire / August 4, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with ...
BEIJING, CN / ACCESS Newswire / May 16, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.
CASI Pharmaceuticals (NASDAQ:CASI) stock rocketed higher in pre-market trading this morning, but it’s not due to any positive news from the biopharmaceutical company. Instead, the rise in price for ...
CASI Pharmaceuticals Inc (NASDAQ:CASI) shares jumped 12.4% after the clinical-stage biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) granted clearance for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results